Security key
29405E208
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB)
CUSIP: 29405E208
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 505,777
- Total 13F value
- $307,294
- Share change
- +17,550
- SEC-reported price per share
- $0.63
- Number of holders
- 17
- Value change
- -$15,307
- Number of buys
- 9
- Number of sells
- 8
- Shares outstanding
- 1,022,530
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
17
Top holders
10
ENVB full security history
Ownership snapshot
Full 13F holder table
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AdvisorShares Investments...
Disclosed value leader
AdvisorShares Investments...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 23%
Showing 1-6 of 15 holder rows.
Quick read
AdvisorShares Investments LLC leads the comparable SEC ownership view at 23%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AdvisorShares Investments LLC's linked filing trail.
Comparable ownership
Top 5
AdvisorShares Investments LLC
23%
HRT FINANCIAL LP
6.2%
CITADEL ADVISORS LLC
3.9%
Virtu Financial LLC
3.3%
BlackRock Finance, Inc.
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC |
13F
Company
|
23%
|
$238,833
238,833 shares
|
— | 31 Mar 2024 |
| HRT FINANCIAL LP |
13F
Company
|
6.2%
|
$63,000
63,026 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
3.9%
|
$40,104
40,104 shares
|
— | 31 Mar 2024 |
| Virtu Financial LLC |
13F
Company
|
3.3%
|
$34,000
33,835 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
2.9%
|
$29,578
29,578 shares
|
— | 31 Mar 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
1.8%
|
$18,247
18,247 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
505,777
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
17
Q2 2024 holders
17
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|